Joseph Banis, MD
Plastic and Reconstructive Surgery · Louisville, KYNPI 1093717274
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.0%), food and beverage and education — rather than concentrated in one kind of arrangement. AbbVie accounts for 62.8% of it on its own, with 19 other manufacturers making up the rest. Among plastic and reconstructive surgery clinicians in KY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 232 payments — averaging $66.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$10K
- Merz North America, Inc.$3K
- Sientra, Inc.$707
- RTI Surgical, Inc$673
- Revance Therapeutics, Inc.$169
- Musculoskeletal Transplant Foundation Inc.$155
- plus $724 from 14 others
What the payments were for
- Speaking & faculty fees$8,15453%
- Food & beverage$7,07746%
- Education$1471%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 125 | $9,658 |
| Merz North America, Inc. | 23 | $3,291 |
| Sientra, Inc. | 29 | $707 |
| RTI Surgical, Inc | 11 | $673 |
| Revance Therapeutics, Inc. | 7 | $169 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $155 |
| Smith+Nephew | 7 | $123 |
| Bsn Medical Inc | 1 | $122 |
| Integra Lifesciences Corporation | 8 | $119 |
| Galderma Laboratories, L.p. | 6 | $75 |
| Polymedics Innovations Inc. | 1 | $58 |
| Organogenesis Inc. | 3 | $52 |
| Baudax Bio Inc. | 2 | $33 |
| Merck | 2 | $24 |
| Mentor Worldwide LLC | 1 | $23 |
| TEI Biosciences Inc | 1 | $23 |
| Motiva USA, LLC | 1 | $21 |
| TELA Bio, Inc. | 1 | $20 |
| Acelrx Pharmaceuticals, Inc. | 1 | $18 |
| Pacira Pharmaceuticals Incorporated | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,377 in reported general payments places this provider in the 90th percentile of 43 plastic and reconstructive surgery providers in Kentucky.
See all plastic and reconstructive surgery providers in Kentucky →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 13 | $41 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Louisville
- Brian ThorntonLouisville$1.1M
- Mark CharikerLouisville$48K
- Tathyana FenstererLouisville$19K
- Angela PrescottLouisville$7K
- Terry McCurryLouisville$6K
- Thomas OdanielLouisville$5K
- Bradon WilhelmiLouisville$5K
- Joshua SpiegelLouisville$4K
- Dexter WeeksLouisville$3K
- Alexander DigenisLouisville$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.